@siemionowkris Avatar @siemionowkris Kris Siemionow, MD, PhD

Kris Siemionow, MD, PhD posts on X about ai, in the, this is, stocks the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-----] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 15.63% finance 13.28% countries 6.25% exchanges 2.34% currencies 2.34% cryptocurrencies 1.56% travel destinations 1.56% technology brands 0.78% automotive brands 0.78%

Social topic influence ai 6.25%, in the 6.25%, this is 5.47%, stocks 3.91%, business 3.91%, company 3.91%, study 3.91%, $rgnx #14, up to 3.13%, ipo 3.13%

Top accounts mentioned or mentioned by @nextatv @nature @kardiolytics @marekfanatyk @liveuamap @visegrad24 @dystrogen @spectatorindex @biopharmiq @zebulgar @davidasinclair @theficouple @razibkhan @joepompliano @theeconomist @heartflow @stratcomcentre @marcinbosacki @nestle @lsjmd

Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Illumina, Inc. (ILMN) Pfizer, Inc. (PFE) Merck & Co., Inc. (MRK) Novo-Nordisk (NVO) Atai Life Sciences B.V. (ATAI) Oruka Therapeutics, Inc. Common Stock (ORKA) Abivax SA (ABVX) Lyra Therapeutics, Inc. (LYRA) LYRA (LYRA) GSK plc (GSK) Novavax Inc (NVAX) Pharming Group N.V. (PHAR) Revolution Medicines, Inc. (RVMD) AbbVie Inc (ABBV) AstraZeneca PLC (AZN) Medtronic PLC (MDT) Measurable Data Token (MDT) uniQure N.V. (QURE)

Top Social Posts

Top posts by engagements in the last [--] hours

"The #neural implant has been used to stimulate the spinal cord of animal models with #spinalcordinjury and now could be used to develop new treatments for human patients with paralysis. #Neuralink https://medicalxpress.com/news/2020-09-link-brains-d-implants.html https://medicalxpress.com/news/2020-09-link-brains-d-implants.html"
X Link 2020-09-22T17:46Z [----] followers, [--] engagements

"@YWNReporter @Liveuamap He fell for the ol push versus pull door trap. The best of the best of the russian military. No wonder they ran out of fuel"
X Link 2022-03-02T09:36Z [----] followers, [--] engagements

"@Liveuamap @GirkinGirkin Good ol General Mud very successful against tanks"
X Link 2022-03-03T07:48Z [----] followers, [--] engagements

"@brithume My favorite sentence by the experts - Mobile engagements would benefit Russian forces which are far better trained and equipped to conduct coordinated air and land maneuver warfare than their Ukrainian opponents - time to look for another gig"
X Link 2022-03-17T22:10Z [----] followers, [--] engagements

"@zebulgar For opposite effect wear a Che Guevara T shirt during the interview"
X Link 2022-03-31T23:26Z [----] followers, [--] engagements

"@hubermanlab @APompliano Churchill lived to be [--] seems candle routine worked for him"
X Link 2022-11-26T01:56Z [----] followers, [--] engagements

"🚀 $ATAI (now AtaiBeckley near-term drivers in 2026: Fresh from their Jan [--] update ahead of JPM Healthcare Conf. - Positive Ph2b for BPL-003 in TRD: Single-dose durable effects; OLE backs 12mg repeat. - FDA EoP2 mtg Q1'26 for Ph3 guidance; potential Ph3 start Q2'26. - More catalysts: EMP-01 topline Q1'26; VLS-01 H2'26. - Corp: US redomicile NASDAQ Biotech Index add; funded to [----]. Post-Beckley merger synergies fueling psychedelic MH boom Watch #ATAI #Biotech #Stocks https://www.ataibeckley.com https://www.ataibeckley.com"
X Link 2026-02-09T17:07Z [----] followers, [---] engagements

"@BitcoinNewsCom Rich people will move and middle class will not buy stocks"
X Link 2026-02-12T19:40Z [----] followers, 10K engagements

"@EricTopol Capacity is now at 26k patients/day as per @COVID2019tests. It should increase significantly with new Roche device approved"
X Link 2020-03-15T01:41Z [----] followers, [--] engagements

"@davidasinclair So has the ancient practice of bloodletting been vindicated (validated) 🤔"
X Link 2021-09-12T00:14Z [----] followers, [--] engagements

"@zebulgar Wait till you take a German train. You will feel better"
X Link 2022-01-18T15:13Z [----] followers, [--] engagements

"@iga_swiatek"
X Link 2022-04-06T20:28Z [----] followers, [--] engagements

"@RobertPszczel In Polish is this is called skurwysystwo"
X Link 2022-10-24T20:59Z [----] followers, [--] engagements

"🚨 Biotech Buzz at #JPM2026: Key pre-market updates from publicly traded firms. - Oruka Therapeutics $ORKA: Positive Phase [--] data for psoriasis drug ORKA-002; EVERLAST-B trial starts for ORKA-001. - Abivax $ABVX: Shares up 23% on M&A rumors with US pharma interest. - BioNTech $BNTX: [----] outlook highlights oncology milestones; +1% pre-market. - Relmada $RLMD: FDA alignment on REL-1017 for depression; Phase [--] data expected. - ANI Pharma $ANIP: Strong 2025-26 guidance in rare diseases/generics. - Foghorn $FHTX: Equity raise & oncology advances. - Scholar Rock $SRRK: Phase [--] success in SMA;"
X Link 2026-01-12T12:47Z [----] followers, [----] engagements

"$LYRA ouch Lyra Therapeutics just announced they're suspending development of LYR-210 for chronic rhinosinusitis despite positive Phase [--] ENLIGHTEN [--] data last year. Massive workforce cut (all [--] remaining staff) exploring strategic alternatives/sale. Cash runway to Q3 [----]. Stock tanking hard in pre-market. Brutal day for biotechs. 😔 (Not investment advice) #biotech #LYRA https://twitter.com/i/web/status/2010709988243546218 https://twitter.com/i/web/status/2010709988243546218"
X Link 2026-01-12T13:46Z [----] followers, [---] engagements

"$SRPT stock is tanking hard after Sarepta's Q4 [----] Elevidys sales miss$110M vs. $120M expected continuing the slide from Q3. Safety issues and manufacturing woes piling on. Competitors like Solid Bio and REGENXBIO eyeing the DMD market.#Biotech"
X Link 2026-01-12T17:38Z [----] followers, [----] engagements

"$ILMN Illumina just dropped a major announcement at #JPMHC26 today (Day 2): the Billion Cell Atlas the world's largest genome-wide genetic perturbation dataset designed to supercharge AI-powered drug discovery. Built through their new BioInsight business it maps how [--] billion individual cells respond to CRISPR-edited genetic changes (switching [-----] genes on/off) across 200+ disease-relevant cell lines. Already partnering with heavy hitters like $AZN (AstraZeneca) $MRK (Merck) and $LLY (Eli Lilly) as founding participants Merck plans to use it directly to train their AI models for precision"
X Link 2026-01-13T22:47Z [----] followers, [---] engagements

"Major #biotech deals continue and its just Tuesday $GSK acquires Rapt Therapeutics $RAPT for $2.2 billion This deal centers on Rapt's experimental anti-IgE antibody aimed at preventing food allergy reactions. It's a significant move in allergy/immunology highlighting Big Pharma's push into mid-stage assets. $PFE Pfizer inks a $530 million deal with Novavax $NVAX Pfizer gains access to Novavax's adjuvant technology for two undisclosed programs boosting vaccine innovation efforts. Ongoing M&A momentum from the J.P. Morgan Healthcare Conference (JPM26) wrap-up includes renewed optimism around"
X Link 2026-01-20T17:04Z [----] followers, [----] engagements

"** $RGNX REGENXBIO's Pivotal Year: Key Gene Therapy Programs** Amid FDA tightening evidentiary standards for rare disease approvals REGENXBIO (NASDAQ: $RGNX) faces defining [----] milestones with its lead programs: RGX-121 for Hunter syndrome (MPS II) and RGX-202 for Duchenne muscular dystrophy (DMD). ### RGX-121 for Hunter Syndrome (MPS II) Rare X-linked disorder (1 in 100000-170000 male births) caused by IDS enzyme deficiency leading to glycosaminoglycan buildup and severe neurocognitive decline. No curative options cross the blood-brain barrier effectively. RGX-121: One-time AAV9 gene"
X Link 2026-01-22T13:00Z [----] followers, [----] engagements

"#Biotech catalysts heating up this week Watch these companies reporting stock moving news: - $AQST: PDUFA for needle-free Anaphylm epinephrine - $PHAR: PDUFA for leniolisib expansion to kids with APDS - $KOD: Ph3 readout for tarcocimab in eye diseases - $KZIA: Ph1b data for paxalisib in brain cancer Volatility incoming #Stocks #FDA" https://twitter.com/i/web/status/2015426673823351068 https://twitter.com/i/web/status/2015426673823351068"
X Link 2026-01-25T14:08Z [----] followers, [----] engagements

"BREAKING: Merck $MRK bails on $RVMD takeovercouldn't stomach the price tag on a $30B deal (WSJ). Valuation chasm kills it. Takeover premium vanishes overnight. $RVMD heads for a Monday gut punch but RAS data bombs in 1H26 still loom large. Door wide open for AbbVie or whoever has the balls & cash. Biotech M&A circus rolls on. 🔥 #RVMD #Biotech #MNA https://twitter.com/i/web/status/2015532856391372982 https://twitter.com/i/web/status/2015532856391372982"
X Link 2026-01-25T21:10Z [----] followers, [----] engagements

"Big news from $SRPT today: Sarepta Therapeutics released positive three-year topline data from the EMBARK Phase [--] study of ELEVIDYS showing the gene therapy significantly slows Duchenne muscular dystrophy (DMD) progression in ambulatory patients aged 4-7. Treated kids maintained or improved key motor functions like NSAA scores while untreated patients declineda durable treatment effect with no new safety signals. Stock popped around 9-10% on the update. My take: This is a strong win for Sarepta shareholders. DMD is a relentlessly progressive disease so three years of functional stability or"
X Link 2026-01-26T18:48Z [----] followers, [----] engagements

"$RGNX sharply lower today down 30% in pre market trading after FDA clinical holds on RGX-111 & now RGX-121 due to a brain tumor in one MPS I patient. PDUFA for RGX-121 (Feb 8) in jeopardy. Safety signals hit hard in rare disease gene therapy. #Biotech #GeneTherapy"
X Link 2026-01-28T13:37Z [----] followers, [----] engagements

"$EIKN Eikon Therapeutics already a $1B+ private fundraising machine under Roger Perlmutter is still capital-hungry enough to hit the public markets for up to $318M in its IPO (targeting $908M valuation at the high end). $MRK Merck is reportedly stepping up with a $30M anchor stake in the offering a nice vote of confidence from Perlmutter's old shop (and likely a pipeline-access play). But will broader investors follow Eikon's burning cash fast on late-stage trials (EIK1001 + Keytruda combo data due H2 2026) a high-throughput platform and no revenue yet. In this cautious biotech window Merck's"
X Link 2026-01-29T12:18Z [----] followers, [----] engagements

"BIG BIOTECH MOVE: AstraZeneca $AZN just inked a massive obesity deal with China's CSPC Pharma up to $18.5B total - $1.2B upfront cash - Ex-China global rights to [--] next-gen programs (incl. once-monthly GLP-1/GIP agonist SYH2082 ready for Phase 1) - Access to AI peptide platform + innovative monthly dosing tech This comes right after AZ's $15B China investment pledge thru [----]. Obesity gold rush heats up chasing Novo & Lilly #Biotech #ObesityDrugs #AstraZeneca #CSPC #PharmaDeals https://twitter.com/i/web/status/2017226012954648915 https://twitter.com/i/web/status/2017226012954648915"
X Link 2026-01-30T13:18Z [----] followers, [----] engagements

"$MDT Medtronic just announced its intent to acquire CathWorks exercising an option following their [----] strategic partnership and co-promotion agreement. CathWorks' AI-powered FFRangio System provides wire-free drug-free physiologic assessment of the entire coronary tree from routine angiogramsrevolutionizing cath lab workflows and enabling more personalized confident decisions for patients with coronary artery disease. This acquisition strengthens Medtronic's interventional cardiology portfolio and pushes toward new standards of care in treating CAD. Valued at up to $585M (with potential"
X Link 2026-02-03T14:48Z [----] followers, [---] engagements

"Does the market always know $QURE"
X Link 2026-02-03T16:07Z [----] followers, [----] engagements

"$PFE Pfizer's $10B Metsera buy faces early questions after Feb [----] Phase 2b data for PF'3944 (MET-097i) showed 10-12% placebo-adjusted weight loss at [--] wkssolid for monthly dosing but trailing Lilly/Novo leaders per cross-trial views. Stock dipped; critics see it as another big M&A bet amid prior flops. Recent M&A setbacks (per reports activist Starboard Value critiques earnings): - Global Blood Therapeutics ($5.4B 2022): Oxbryta withdrawn Sep [----] due to increased VOCs/deathsnear-total loss/write-off cited as major value destruction. - Broader $70B+ post-COVID spree (incl. Seagen $43B)"
X Link 2026-02-03T17:18Z [----] followers, [---] engagements

"$NVO continues its strategy of destroying shareholder value"
X Link 2026-02-03T17:42Z [----] followers, 13.5K engagements

"Biotech heating up Feb 5: $LLY crushes Q4 w/ $19B rev (Mounjaro/Zepbound booming) guides $80-83B for '26 stock soaring. $NVO faces headwinds w/ grim outlook shares down sharply. Eikon Therapeutics upsized $381M IPO (largest since '24). Pipeline moves: Lilly drops [--] assets incl Prevail gene tx; Novartis axes [--] Ph1s. Obesity rivalry intensifies $XBI https://twitter.com/i/web/status/2019387587870269758 https://twitter.com/i/web/status/2019387587870269758"
X Link 2026-02-05T12:28Z [----] followers, [----] engagements

"Could be a wild week for the $RGNX stock. FDA placed a clinical hold on the program late last month due to a tumor case in the related RGX-111 (MPS I) study shared risks cited. The company has its PDUFA decision for RGX-121 (clemidsogene lanparvovec) a one-time gene therapy for MPS II (Hunter syndrome). Approval could unlock a Priority Review Voucher + major upside in this ultra-rare space. #Biotech #RGNX #GeneTherapy #PDUFA https://twitter.com/i/web/status/2020517190877773849 https://twitter.com/i/web/status/2020517190877773849"
X Link 2026-02-08T15:16Z [----] followers, [----] engagements

"@theficouple @razibkhan That 99% of billionaires did not attend any of the listed schools"
X Link 2026-02-11T19:46Z [----] followers, [----] engagements

"@Dr_da_Vinci @theficouple @razibkhan Keep in mind the colleges are giving you graduate data for the last [--] years or so whereas you quote a one year data point from Forbes"
X Link 2026-02-11T20:02Z [----] followers, [---] engagements

"The other way of reading this is - only 15% of Harvard students feel confident they would actually get an A"
X Link 2026-02-11T20:27Z [----] followers, [---] engagements

"BridgeBio Pharma $BBIO stock up 20% premarket after dropping positive Phase [--] topline results for oral infigratinib in kids with achondroplasia (most common form of dwarfism) The PROPEL [--] trial hit its primary endpoint: +2.1 cm/year annualized height velocity vs placebo (stat sig LS mean diff +1.74 cm/year). It even showed the first statistically significant improvements in body proportionality Outperforms BioMarin's Voxzogo in key growth metrics sets up a strong potential competitor. Plans to file NDA/MAA in 2H [----]. Exciting step for rare disease patients #Biotech #Achondroplasia"
X Link 2026-02-12T12:50Z [----] followers, [----] engagements

"@MarekFanatyk"
X Link 2026-02-13T11:59Z [----] followers, [---] engagements

"@MarekFanatyk Wtedy w T Rowe Price"
X Link 2026-02-13T12:18Z [----] followers, [---] engagements

"@AtulGupta_MD @chrissyfarr Agree with Atul. Try functioning with a pinched nerve for an extra [--] weeks - nothing elective about it for that patient"
X Link 2020-05-05T00:05Z [----] followers, [--] engagements

"Acquisition blocked 🚫 The FTC has halted $EW Edwards Lifesciences' $1.2B bid for JenaValve Technology after months of review. Citing Edwards' prior JC Medical buy they fear monopolization in the aortic regurgitation market. JenaValve's TRILOGY TAVR & JC's J-Valve both target AR. Will another buyer swoop in The is a very hot market in #cardiology #MedTech #FTC #Mergers https://jenavalve.com https://jenavalve.com"
X Link 2026-01-12T14:04Z [----] followers, [---] engagements

"🚨 Biotech catalysts that can move stocks this coming week (Feb 2-8 2026): - $DNLI: WORLD Symposium data on MPS IIIA & Hunter syndrome programs (Feb 5) - $ARTV: AlloNK + ritux in B-NHL poster at Tandem (Feb 5) - $KOD: KSI-101 24-wk macular edema data (Feb 7) - $RGNX: RGX-121 PDUFA for MPS II gene therapy (Feb 8) but clinical hold news last week adds huge risk/volatility Also $ILMN earnings Feb [--]. Binary week ahead with big % swings possible. DYOR #Biotech https://twitter.com/i/web/status/2017932159844032894 https://twitter.com/i/web/status/2017932159844032894"
X Link 2026-02-01T12:04Z [----] followers, [----] engagements

"Talk about wild looks like the transportation segment sell Off is driven by a company that six months ago was selling karaokes 🤔 The sell-off appears to have been sparked by a news release from a Florida firm called Algorhythm Holdings which said its SemiCab unit had boosted customers' freight volumes more than 300% "without a corresponding increase in operational headcount." Prior to August the company's main business was selling karaoke machines according to securities filings. It said it sold the karaoke business in August and changed its name to Algorhythm from The Singing Machine"
X Link 2026-02-12T19:24Z [----] followers, [---] engagements

"$KRYS trading strong near $276 ahead of Q4/full-year [----] earnings tomorrow (Feb [--] pre-market). Preliminary Vyjuvek sales hit $106-107M for Q4 full-year $388-389M (+34% YoY). Fresh RMAT designation for KB707 in NSCLC adds pipeline upside. Solid gene therapy story with revenue & growth. Earnings call at 8:30 AM ET watch for guidance. #KRYS #Biotech #Earnings https://twitter.com/i/web/status/2023405070524846544 https://twitter.com/i/web/status/2023405070524846544"
X Link 2026-02-16T14:32Z [----] followers, [---] engagements

"@ua_industrial Elite Russian troops wearing tennis shoes. Probably to help them run away once they encounter actual resistance"
X Link 2022-03-01T12:07Z [----] followers, [---] engagements

"@nexta_tv russian crme de la crme. These guys excelled at shooting unarmed villagers in third world countries. Not surprised they didnt even last 24hrs when facing a real army"
X Link 2022-03-01T16:47Z [----] followers, [--] engagements

"@nexta_tv Looks ready to welcome Ukrainian refugees"
X Link 2022-03-05T12:22Z [----] followers, [--] engagements

"@TadeuszGiczan We have seen this before"
X Link 2022-03-06T17:50Z [----] followers, [--] engagements

"@visegrad24 mazel tov"
X Link 2022-03-07T01:51Z [----] followers, [--] engagements

"@nexta_tv Last guy who said those very words:"
X Link 2022-03-13T23:04Z [----] followers, [---] engagements

"@nexta_tv Did the chancellor see this one ( I bet Putin put it up)"
X Link 2022-03-17T21:07Z [----] followers, [--] engagements

"@nexta_tv Nothing to see here"
X Link 2022-03-17T21:08Z [----] followers, [--] engagements

"@J_Jaraczewski They should consider themselves lucky that the President did not land in Szczebrzeszyn"
X Link 2022-03-25T15:01Z [----] followers, [--] engagements

"@nexta_tv The onboard tomahawk missiles are within range of Moscow. They can be served with or without a nuclear warhead. https://en.m.wikipedia.org/wiki/Tomahawk_(missile) https://en.m.wikipedia.org/wiki/Tomahawk_(missile)"
X Link 2022-03-27T22:00Z [----] followers, [--] engagements

"@christopherrufo What about alligators eating children did they take care of that too https://amp.theguardian.com/us-news/2016/jun/15/disney-world-alligator-attack-boy-search https://amp.theguardian.com/us-news/2016/jun/15/disney-world-alligator-attack-boy-search"
X Link 2022-03-29T22:44Z [----] followers, [--] engagements

"@Liveuamap @_catiko Yet the road has fewer potholes then the streets in Chicago"
X Link 2022-03-30T19:57Z [----] followers, [--] engagements

"With our @dystrogen DT-DEC01 clinical posters at the @MDAorg conference demonstrating objective improvements on electromyography (EMG) as well as subjective improvements on functional outcome measures in patients with #duchenne muscular dystrophy"
X Link 2023-03-22T16:20Z [----] followers, [----] engagements

"$MDG Medicalgorithmics 👀"
X Link 2023-06-13T14:37Z [----] followers, [----] engagements

"@alitaylor If you want to know why that is just follow the money"
X Link 2023-06-13T16:35Z [----] followers, 14K engagements

"@JoePompliano Best business advice ever"
X Link 2023-06-13T22:06Z [----] followers, [----] engagements

"Exciting news and a big milestone @dystrogen Therapeutics announces the approval of their Clinical Trial Application (CTA) to initiate a phase 1/2 clinical trial of DT-DEC01 for the treatment of Duchenne Muscular Dystrophy #duchennemusculardystrophy #dmd #clinicaltrial https://dystrogen.com/wp-content/uploads/2023/12/Dystrogen-Therapeutics-Announces-Approval-of-Clinical-Trial-Application-CTA-to-Initiate-a-Phase-1_2-Clinical-Trial-of-DT-DEC01-for-the-Treatment-of-Duchenne-Muscular-Dystrophy-.pdf"
X Link 2023-12-20T17:35Z [----] followers, [----] engagements

"@spectatorindex Is this the same group from 2hrs ago"
X Link 2024-07-01T17:17Z [----] followers, [----] engagements

"@nexta_tv All [--] of them"
X Link 2024-09-09T16:14Z [----] followers, [----] engagements

"@venturetwins When investing other peoples money: Revenue = making money When investing your own money: profit = making money"
X Link 2024-09-28T16:07Z [----] followers, [----] engagements

"Today our portfolio company $Medicalgorithmics announced CE mark for revolutionary Virtual Cardiac Stress Test (VCAST) an AI-driven tool for the diagnosis of #coronary artery disease. It utilizes advanced algorithms to analyze data from CT scans providing non-invasive and detailed insights into coronary blood flow and the hemodynamic significance of #arterial stenosis (narrowing). VCAST offers a safer and more accessible alternative to traditional invasive diagnostic methods like Fractional Flow Reserve (FFR) which typically involves inserting a pressure wire into coronary arteries. The"
X Link 2024-10-17T13:14Z [----] followers, [----] engagements

"@TheEconomist Reads like a satire"
X Link 2024-10-31T15:29Z [----] followers, [---] engagements

"@TheEconomist Guys you really need to stop campaigning. The people have spoken"
X Link 2024-11-09T17:24Z [----] followers, [----] engagements

"@unusual_whales A hip fracture in someone her age carries a [--] day mortality rate of 30%"
X Link 2024-12-13T20:28Z [----] followers, [----] engagements

"@nntaleb Curious how cheap humanoid robots may impact this dynamic"
X Link 2025-01-06T13:20Z [----] followers, [----] engagements

"@shaunmmaguire Preemptive pardons are a slippery slope"
X Link 2025-01-20T17:06Z [----] followers, [----] engagements

"@spectatorindex Always wondered why other administrations did not take this step"
X Link 2025-01-21T01:09Z [----] followers, [----] engagements

"@Atul_Gawande This pain killer did not do better then a mild opioid (hydrocodone bitartrate and acetaminophen [--] mg/325 mg administered every six hours) putting its postoperative use in question"
X Link 2025-01-31T18:34Z [----] followers, [---] engagements

"@heimbergecon Music to Swiss ears"
X Link 2025-02-01T13:05Z [----] followers, [---] engagements

"@jarokrolewski Dzisiaj Polski algorytm AI opublikowany w @NatureMedicine Niecodzienne zjawisko. DRAI stworzony przez Medicalgorithmics skutecznie zastpuje kardiologa. https://www.nature.com/articles/s41591-025-03516-x/metrics https://www.nature.com/articles/s41591-025-03516-x/metrics"
X Link 2025-02-10T13:45Z [----] followers, [----] engagements

"@Nature If only there was a vaccine"
X Link 2025-03-19T20:13Z [----] followers, [---] engagements

"@KobeissiLetter This would imply that Huawei chips are equivalent which means NVidia would have lost market share regardless of trade export restriction"
X Link 2025-04-21T11:38Z [----] followers, [----] engagements

"@JavierBlas Only logical explanation is aliens"
X Link 2025-04-28T21:28Z [----] followers, [----] engagements

"$SRPT if one government post has this much impact on your survival something is wrong with your business model"
X Link 2025-05-06T17:26Z [----] followers, [----] engagements

"@SecKennedy America also consumes 80% of the worlds opioids this needs to stop"
X Link 2025-05-12T22:07Z [----] followers, [---] engagements

"Dlaczego mylisz e te umowy podpisujemy 😎"
X Link 2025-06-26T13:37Z [----] followers, [---] engagements

"Medicalgorithmics isnt just signing new clientswere rapidly onboarding them. By the end of July we had already integrated [--] of the [--] clients signed so far in [----]. This acceleration in go-lives helped drive a 33% year-over-year revenue increase for the month. Why this matters: ✅ Accelerated revenue realization Faster integration means earlier activation of our AI diagnostic platformenabling clients to begin commercial use sooner and contributing to recurring revenue earlier in the contract lifecycle. ✅ Operational scalability Smooth onboarding across multiple geographies demonstrates that"
X Link 2025-08-01T07:46Z [----] followers, [---] engagements

"https://www.linkedin.com/posts/dziennik-gazeta-prawna_stworzony-w-polsce-system-ai-do-analizy-ugcPost-7359482882450513920-LuGautm_medium=ios_app&rcm=ACoAAACCiBUBnSUz_Sw3-j8_g96GktigeeuOPac&utm_source=social_share_send&utm_campaign=copy_link https://www.linkedin.com/posts/dziennik-gazeta-prawna_stworzony-w-polsce-system-ai-do-analizy-ugcPost-7359482882450513920-LuGautm_medium=ios_app&rcm=ACoAAACCiBUBnSUz_Sw3-j8_g96GktigeeuOPac&utm_source=social_share_send&utm_campaign=copy_link"
X Link 2025-08-08T10:37Z [----] followers, [---] engagements

"@IterIntellectus"
X Link 2025-08-31T11:52Z [----] followers, [----] engagements

"@FinancialTimes No more herd immunity Failure in leadership how could you propose such a concept in the first place with all that Italy data"
X Link 2020-03-18T16:01Z [----] followers, [--] engagements

"@davidasinclair For context exhaled air contains 1617% oxygen"
X Link 2023-05-24T13:37Z [----] followers, [----] engagements

"#Poland real gdp grew 3.2% in the second quarter making the country a solid leader in the EU over the last [--] years. This is some real #GDP growth"
X Link 2024-08-14T12:21Z [----] followers, [----] engagements

"@spectatorindex And its been less then [--] hrs since election"
X Link 2024-11-08T22:55Z [----] followers, 23.7K engagements

"The headline speaks for itself: a major milestone for our portfolio company $Medicalgorithmics with a contract worth 46M PLN ($11.5M). But this is just the beginning. The United States presents even greater opportunities for growth. Analysis of Medicare payment data reveals over [---] Independent Diagnostic Testing Facilities (IDTFs) generating significant revenue from #EKG analysis. These facilities could greatly enhance their efficiency and diagnostic yield with Medicalgorithmics innovative software solutions. Exciting times ahead #cardiology #rhythym #electrophysiology #AI"
X Link 2025-01-24T11:37Z [----] followers, [----] engagements

"@Nature If they cant get funding in the US then their chance to be funded elsewhere is nil"
X Link 2025-03-15T14:51Z [----] followers, [----] engagements

"🫀 @Heartflow IPO Sizing Up the Opportunity HeartFlow a pioneer in non-invasive coronary artery disease (CAD) diagnosis using AI-based CT imaging officially filed for an IPO under ticker HTFL. The company plans to raise $100 million on Nasdaq primarily to pay down debt expand commercialization efforts and enhance R&D . Financials are impressive: $125.8 million in annual revenue for [----] (up 44% YoY) Q1 [----] revenue of $37.2 million growing 39% year-over-year However losses persist: Q1 [----] net loss of $32.3 million Market opportunity HeartFlow estimates a $5 billion+ U.S. addressable"
X Link 2025-07-24T07:05Z [----] followers, [----] engagements

"Proud of my moms work in moving this field forward A groundbreaking face transplant gave Katie Stubblefield a second chance at life. Follow her family's story https://t.co/kWmroLntGW https://t.co/9BN8DDWOJO A groundbreaking face transplant gave Katie Stubblefield a second chance at life. Follow her family's story https://t.co/kWmroLntGW https://t.co/9BN8DDWOJO"
X Link 2018-08-16T22:13Z [----] followers, [--] engagements

"@AmerMedicalAssn Looks like the AMA would prefer medical schools to train coders instead of doctors so they can sell more CPT code paraphernalia. There is an inherent conflict of interest. AMA should divest the cpt business"
X Link 2019-11-30T17:03Z [----] followers, [--] engagements

"@naval Too bad all the smart kids are working on the next big photo sharing app"
X Link 2020-03-15T01:15Z [----] followers, [---] engagements

"@GovPritzker The #AbbottLaboratories device will be very helpful in implementing widespread testing and provide rapid test results #covid19"
X Link 2020-03-30T02:01Z [----] followers, [--] engagements

"The European Patent Office has granted our #MachineLearning based bony #anatomy segmentation patent - EP3470006A1. This approach is critical to designing autonomous intelligent solutions for #spine and #orthopedic procedures"
X Link 2020-08-16T00:57Z [----] followers, [--] engagements

"Happy to announce that our validation study using Holo #ArtificialIntelligence was published today: Autonomous lumbar spine pedicle screw planning using machine learning: A validation study congrats to the team @HoloSurgical https://www.jcvjs.com/article.aspissn=0974-8237;year=2021;volume=12;issue=3;spage=223;epage=227;aulast=Siemionow;type=3 https://www.jcvjs.com/article.aspissn=0974-8237;year=2021;volume=12;issue=3;spage=223;epage=227;aulast=Siemionow;type=3"
X Link 2021-09-08T15:14Z [----] followers, [--] engagements

"Watch me cannulate [--] pedicles in [--] minutes during a lab using our Holo system. The key to improved workflow is #AR driven improvement in 3D visualization with #AI supported intelligent anatomy recognition and guidance #Neurosurgery #orthotwitter https://youtu.be/TQOjtv4a0TQ https://youtu.be/TQOjtv4a0TQ"
X Link 2022-01-16T18:22Z [----] followers, [--] engagements

"See those [--] green circles Thats our #AI based surgical guidance. Can you make the big circle match the small circle Of course you can. We have added elements of #AR and gamification to make precisely placing #neurosurgery implants easy on the surgeon"
X Link 2022-01-27T18:08Z [----] followers, [--] engagements

"@ArmedForcesUkr In Poland they call these guys Photographers with a big camera. They take pictures of Russian tanks. Please take lots of pictures"
X Link 2022-03-01T13:48Z [----] followers, [--] engagements

"@visegrad24 These are not sanctions this is a peaceful economic operation designed to stabilize russian economy. russians are greeting sanctions with open arms and flowers"
X Link 2022-03-05T13:57Z [----] followers, [---] engagements

"@StratcomCentre @MarcinBosacki This appears to be standing operating procedure for @Nestle During World War II the Swiss companys global operation supplied both sides of the conflict. Nestl won a contract to feed the German Army https://www.nytimes.com/2017/06/27/business/dealbook/nestle-chocolate-milk-coffee-history.html https://www.nytimes.com/2017/06/27/business/dealbook/nestle-chocolate-milk-coffee-history.html"
X Link 2022-03-17T20:11Z [----] followers, [--] engagements

"@StratcomCentre @MarcinBosacki @Nestle Oops In [----] the company agreed to pay $14.6 million to settle Holocaust-era claims that some of its companies in countries under German control used slave labor. As a rule they were not worried or uneasy about the situation and as long as production was maintained"
X Link 2022-03-17T20:37Z [----] followers, [--] engagements

"@SahilBloom @anafabrega11 I recommend reading a history of private life to gain insights of how Stoics applied their principles in real time. some may be quite shocking"
X Link 2022-04-29T15:45Z [----] followers, [--] engagements

"@lloydblankfein The only way you become fabulously rich in Russia is aggravation"
X Link 2023-06-26T13:01Z [----] followers, [----] engagements

"Congratulations to the @dystrogen team for their latest publication: Safety and Efficacy of DT-DEC01 Therapy in Duchenne Muscular Dystrophy Patients: A [--] - Month Follow-UpStudy After Systemic Intraosseous Administration https://link.springer.com/article/10.1007/s12015-023-10620-3 https://link.springer.com/article/10.1007/s12015-023-10620-3"
X Link 2023-09-14T16:31Z [----] followers, [----] engagements

"Big news this morning has received #FDA clearance for the groundbreaking Deep Rhythm platform a cloud-based #ECG analytics system. This next-generation web browser-based platform leverages cutting-edge DeepRhythmAI algorithms to provide unparalleled performance in cardiac monitoring. The FDA approval allows Medicalgorithmics S.A. to commercialize this innovative solution in the USA opening new business opportunities and enhancing the company's competitive edge in the cardiac diagnostics market. Were thrilled to bring this advanced technology to healthcare providers and patients improving"
X Link 2024-06-24T07:01Z [----] followers, [----] engagements

"@JoePompliano @WHOOP So he stopped running and his heart rate went down is what you are saying"
X Link 2024-07-03T07:37Z [----] followers, [----] engagements

"Congratulations to @lsjMD the entire research team and #medicalgorithmics on this ground breaking #AI study in #Cardiology presented today at the #ESCCongress #ECG #arrhythmia #cardiac"
X Link 2024-08-30T13:37Z [----] followers, [----] engagements

"@MKBHD My advice is kill the wallpaper app say a bunch of stuff how much you learned and how hard it is to be a developer that you will review products from a different perspective etc. etc. etc. move on"
X Link 2024-09-25T21:38Z [----] followers, [----] engagements

"@p_maverick_b He wrote a book called Dancing Naked in the Mind Field. Worth a read"
X Link 2024-10-15T17:28Z [----] followers, 18.4K engagements

"@Nature Wait until they see the scenes from Amsterdam that should give them cause for alarm"
X Link 2024-11-08T14:47Z [----] followers, [----] engagements

"@visegrad24 Afd just added another 5% on their way to majority in February elections"
X Link 2024-12-31T16:50Z [----] followers, [----] engagements

"It is not every day that your company $Medicalgorithmics has its FDA cleared AI algorithms published in @nature medicine. This is the world's largest study of AI for cardiac arrhythmia diagnosis to date including [------] days of ECG data from [-----] adult patients [--] cardiology KOLs. The results are striking. DRAI demonstrated substantially higher sensitivity for detection of critical arrhythmias including atrial fibrillation complete heart block pauses supraventricular and ventricular tachycardia. The rate of false negative findings with DRAI was low [---] per [----] patients compared to [----] per"
X Link 2025-02-10T13:09Z [----] followers, [----] engagements

"@Nature Of course Nature would never ask scientists do to work on its behalf without pay"
X Link 2025-03-17T20:21Z [----] followers, [----] engagements

"@calleymeans For reference a can of breastmilk contains [--] grams of Lactose (sugar). Babies need sugar from somewhere"
X Link 2025-04-10T12:59Z [----] followers, [---] engagements

"@MichaelAArouet What people often forget is that one of the main products of a public company is their stock. Tesla is very good at selling their stock making it more expensive"
X Link 2025-04-12T11:15Z [----] followers, [----] engagements

"@TheHumanoidHub Fake it till you make it. Good thing they are not doing blood testing machines"
X Link 2025-04-12T22:52Z [----] followers, [----] engagements

"@SolanaSensei Europeans appear to be successfully transitioning away from traditional energy sources"
X Link 2025-04-28T15:33Z [----] followers, [----] engagements

"Considering 2M euro grant per researcher as a bare minimum that means enough cash for [--] scientists per member state"
X Link 2025-05-05T22:36Z [----] followers, [----] engagements

"@itslinklauren Guess they like benzene based food dyes in kids cereals"
X Link 2025-05-14T18:58Z [----] followers, [---] engagements

"Whats new and exciting about The newly released FDA cleared software has a nearperfect sensitivity (99.9%) for ruling out lifethreatening events. A new Nature Medicine study reveals DeepRhythmAI identified 98.6% of critical arrhythmias in 14day ECGs versus 80.3% for human technicians14 fewer missed serious events #Cardiology #electrophysiology #arrhythmia #medtech #AI #medicalgorithmics http://Medicalgorithmics.com http://Medicalgorithmics.com"
X Link 2025-06-20T13:19Z [----] followers, [----] engagements

"More good news from Medicalgorithmics The company just signed a global supply deal with @cardioscanAU one of the worlds top cardiac diagnostics providers running 800000+ tests/year across [--] countries 🌍🫀 (so a big opportunity for MDG remember- we get paid per test report). Our DeepRhythmAI & DeepRhythm Platform will be powering Cardioscans EKG analysis (post-integration & regulatory OK). The algorithms and platform were developed by our amazing #Poland based R&D team and together with help from powerhouse cardiac researcher @lsjMD were recently featured in @Nature (link to study in next"
X Link 2025-06-26T11:05Z [----] followers, [----] engagements

"13 - thats the number of contracts signed by Medicalgorithmics this year. Why are we signing record numbers of contracts Because customers value clinically validated software. Our algorithms are among the best in the worldpeer-reviewed in Nature Medicineand our workflows help partners scale ECG services efficiently. #AI #medtech #ECG https://www.medicalgorithmics.com/new-contract-in-belgium-with-byteflies-medicalgorithmics-achieves-record-number-of-ai-powered-diagnostic-agreements/ http://Medicalgorithmics.com"
X Link 2025-07-07T08:13Z [----] followers, [----] engagements

"New Patent Granted for #Medicalgorithmics Why is this important This is an extremely competitive space with billions of dollars invested by a handful of companies racing to transform cardiac diagnostics. The newly granted European patent makes @Kardiolytics (a $Medicalgorithmics subsidiary) one of the global leaders in AI-powered assessment and stratification of coronary artery disease. 🌍 Coronary artery disease affects over [---] million people worldwide and non-invasive fast and accurate diagnostic tools are urgently needed. VCAST is now protected in both the U.S. and Europereinforcing our"
X Link 2025-07-11T07:39Z [----] followers, [----] engagements

"🚨Big step forward for Medicalgorithm we've signed our first VCAST distribution deal with NexGen MediQ bringing our AI-powered coronary CT analysis to Scandinavia. This is also important for me personally - since we started @Kardiolytics in [----] a lot of hard work went into developing and certifying this technology so this first customer has special significance. Ok back to business why this matters 👇 ✅ Commercial Launch: VCAST is now entering its first commercial phase post-CE mark ✅ Market Expansion: Scandinavias cardiology device market is worth $340M+ and growing ✅ AI Leadership: VCAST"
X Link 2025-07-29T09:01Z [----] followers, [----] engagements

"In the upcoming IPO @Heartflow eyes a $1.32 billion valuation. The Mountain View California-based Heartflow is seeking up to $212.5 million by offering [----] million shares priced between $15 and $17 apiece. We see this as a very positive sign for our VCAST @kardiolytics #cad #cardiology #Atherosclerosis #diagnostics https://www.reuters.com/business/healthcare-pharmaceuticals/bain-capital-backed-heartflow-eyes-132-billion-valuation-medtech-ipos-rebound-2025-08-01/"
X Link 2025-08-05T05:18Z [----] followers, [---] engagements

"🚨 New VCAST contract signed Hot on the heels of our partnership in Scandinavia last week (with Nexgen Mediq) weve just signed a second VCAST agreementthis time in Turkey. @kardiolytics VCAST is our AI-powered non-invasive coronary analysis platform. It builds a detailed 3D model of the heart and analyzes blood flow through the coronary arteries to assess heart attack risk and guide personalized treatment decisions. More access. Faster diagnosis. Smarter care. #AI #Cardiology #HealthTech #VCAST #Medicalgorithmics #Atherosclerosis #coronary"
X Link 2025-08-07T09:30Z [----] followers, [---] engagements

"New research in @Nature reveals that lithium deficiency in the brain may drive Alzheimers disease - and supplementing with lithium orotate restored memory & reversed AD pathology in mice. The study shows that lithium levels drop early in the brain during #Alzheimers progression contributing to hallmark changes like amyloid- plaques tau tangles neuroinflammation synapse loss and cognitive decline. In mice fed a lithium-deficient diet brain pathology worsened significantly. However supplementing with lithium orotate - a form that avoids sequestration by plaques - effectively reversed these"
X Link 2025-08-11T11:04Z [----] followers, [----] engagements

"Polecam artyku w @puls_biznesu #Medicalgorithmics widzi kardiologiczny boom https://www.pb.pl/medicalgorithmics-widzi-kardiologiczny-boom-1247397 https://www.pb.pl/medicalgorithmics-widzi-kardiologiczny-boom-1247397"
X Link 2025-08-28T13:20Z [----] followers, [---] engagements

"$RHHBY Big RNAi validation today: Genentech (Roche) just licensed an undisclosed RNAi program from SanegeneBio $200M upfront + up to $1.5B in milestones SanegeneBio's LEAD platform shines with ligand + enhancer-assisted delivery for extra-hepatic tissues (adipose muscle immune cells) enabling potent durable subcutaneous dosing as infrequent as 2x/year for autoimmune cardiometabolic and obesity targets. Huge vote of confidence in next-gen RNAi beyond the liver. $XBI We are an investor in RNAi for #Huntingtons and other CAG repeat disorders technology via our http://dystrogene.com"
X Link 2026-02-02T17:08Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing